Company intelligence / Profile preview

CCBT

Pleasanton, California, United Statesccbt.ca ↗

Ownership: Private
Development stage: Commercial

Overview

CBT Pharmaceuticals, spun out from Crown Bioscience in California, focuses on oncology therapeutics with four development-stage assets. Two compounds have entered clinical trials, with data presented at conferences. The company emphasizes both monotherapy and combination therapy strategies and has established partnerships for co-development and combination trials globally, especially in China and Australia. Plans were underway to expand into additional countries pending promising clinical data[1].

Therapeutic areas: Oncology
Modalities: Small moleculeMonoclonal antibody
Industry: Biotech

Partnerships

Genor BioPharma (China)[1]Chia Tai TianQing (China)[1]Beijing Pearl Biotechnology (China)[1]

Beyond the preview

Go deeper on CCBT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCBT.

Explore the full profile